Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |